Renal allograft platelet activating factor synthesis during acute cellular rejection

Area of Science:

• Nephrology
• Immunology
• Biochemistry

Background:

• Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammatory and immune responses.
• Acute cellular allograft rejection is a major clinical challenge in kidney transplantation, often leading to graft dysfunction.

Purpose of the Study:

• To characterize the synthesis and metabolism of PAF in canine renal allografts during acute rejection.
• To investigate the molecular species of PAF and lyso-PAF produced by rejecting renal tissue.

Main Methods:

• Canine kidney allografts were induced to reject without immunosuppression.
• Renal cortical and medullary tissues were analyzed for PAF and lyso-PAF production using GC/MS, RIA, and platelet aggregation assays.
• Incubation media were assessed for PAF-hydrolyzing activity.

Main Results:

• Rejecting renal allografts showed significantly increased production of various PAF molecular species (e.g., C16:0 PAF by 18-fold) and lyso-PAF compared to native kidneys.
• Increased PAF production was confirmed by immunoassay and functional platelet aggregation assays.
• Media from rejecting allografts exhibited enhanced PAF hydrolysis activity.

Conclusions:

• Untreated acute cellular rejection dramatically increases the production of biologically active PAF species in renal allografts.
• Elevated levels of lyso-PAF were also observed, alongside a factor promoting rapid PAF hydrolysis.
• These findings highlight PAF's role in renal allograft rejection pathophysiology.